Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001725663-25-000003

Chief Financial Officer gave up 1,734 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2025-09-02 Shares withheld for taxes −1,734 $5.43 $9,416 118,936 D: show line 1 in the form
Loading xslF345X05/wk-form4_1757019718.xml…